EP0909558A3 - Ophthalmische Lösung enthaltend ein Chromanderivat - Google Patents

Ophthalmische Lösung enthaltend ein Chromanderivat Download PDF

Info

Publication number
EP0909558A3
EP0909558A3 EP98115893A EP98115893A EP0909558A3 EP 0909558 A3 EP0909558 A3 EP 0909558A3 EP 98115893 A EP98115893 A EP 98115893A EP 98115893 A EP98115893 A EP 98115893A EP 0909558 A3 EP0909558 A3 EP 0909558A3
Authority
EP
European Patent Office
Prior art keywords
ophthalmic solution
active ingredient
chroman
derivative containing
chroman derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98115893A
Other languages
English (en)
French (fr)
Other versions
EP0909558A2 (de
Inventor
Atsutoshi c/o Santen Pharmaceutical Co. Ltd Ota
Mitsuaki c/o Santen Pharmaceutical Co. LTD Kuwano
Koichi c/o Santen Pharmaceutical Co. LTD. Takada
Chihiro c/o Sanwa Kagaku Kenkyusho Co. Ltd. Hibi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd, Sanwa Kagaku Kenkyusho Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of EP0909558A2 publication Critical patent/EP0909558A2/de
Publication of EP0909558A3 publication Critical patent/EP0909558A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP98115893A 1997-08-29 1998-08-24 Ophthalmische Lösung enthaltend ein Chromanderivat Withdrawn EP0909558A3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP233990/97 1997-08-29
JP23399097 1997-08-29
JP23399097 1997-08-29

Publications (2)

Publication Number Publication Date
EP0909558A2 EP0909558A2 (de) 1999-04-21
EP0909558A3 true EP0909558A3 (de) 1999-10-27

Family

ID=16963824

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98115893A Withdrawn EP0909558A3 (de) 1997-08-29 1998-08-24 Ophthalmische Lösung enthaltend ein Chromanderivat

Country Status (5)

Country Link
EP (1) EP0909558A3 (de)
KR (1) KR19990023971A (de)
CN (1) CN1215591A (de)
CA (1) CA2246224A1 (de)
TW (1) TW422705B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2839847C (en) * 2003-06-13 2016-03-15 Masood A. Chowhan Ophthalmic compositions containing a synergistic combination of two polymers
US7358255B2 (en) * 2003-10-24 2008-04-15 Santen Pharmaceutical Co., Ltd. Therapeutic agent for keratoconjunctival disorder
IL168603A (en) * 2005-05-16 2011-05-31 Resdevco Res And Dev Co Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0437025A2 (de) * 1990-01-12 1991-07-17 Sanwa Kagaku Kenkyusho Co., Ltd. Aldosereduktasehemmer enthaltende Zubereitungen zur Behandlung von Geschwüren
JPH03271291A (ja) * 1990-03-19 1991-12-03 Sanwa Kagaku Kenkyusho Co Ltd 点眼剤
EP0719556A2 (de) * 1994-12-28 1996-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. Mittel zur Behandlung von Keratopathie

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0437025A2 (de) * 1990-01-12 1991-07-17 Sanwa Kagaku Kenkyusho Co., Ltd. Aldosereduktasehemmer enthaltende Zubereitungen zur Behandlung von Geschwüren
JPH03271291A (ja) * 1990-03-19 1991-12-03 Sanwa Kagaku Kenkyusho Co Ltd 点眼剤
EP0719556A2 (de) * 1994-12-28 1996-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. Mittel zur Behandlung von Keratopathie

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 116, no. 18, 4 May 1992, Columbus, Ohio, US; abstract no. 181154, XP002110823 *

Also Published As

Publication number Publication date
CN1215591A (zh) 1999-05-05
TW422705B (en) 2001-02-21
KR19990023971A (ko) 1999-03-25
CA2246224A1 (en) 1999-02-28
EP0909558A2 (de) 1999-04-21

Similar Documents

Publication Publication Date Title
CA2242986A1 (en) Sustained release drug formulations
WO1997028827A1 (fr) Composition ophtalmique possedant une viscosite adaptee
CA2312710A1 (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
WO1997048385A3 (en) Controlled release tablet
EP1695708A3 (de) Pharmazeutische Zusammenstellungen
EP1842567A3 (de) Intraluminale Vorrichtung mit einer therapeutisches Mittel enthaltenden Beschichtung
AU6928596A (en) Heterocyclically substituted biphenylamide derivatives, their preparation and their use as fungicides
CA2243201A1 (en) Process for producing sustained-release preparation
IE790088L (en) Thienohydantoin derivatives
CA2236262A1 (en) Room temperature sterilant for medical devices
KR960028918A (ko) 국소용 약제학적 조성물
CA2011956A1 (en) Sodium hyaluronate composition
WO1996026718A3 (en) Controlled release tablet
AU2494097A (en) Preparation of aqueous polymer dispersions of low viscosity with polymer volume concentrations of at least 50 per cent
EP0505572A4 (en) Iridoide derivative and its use as medicine
IE811654L (en) Ophthalmic composition
AU2002357972A1 (en) Heparin-containing ophthalmic agent
EP0909558A3 (de) Ophthalmische Lösung enthaltend ein Chromanderivat
AU6086099A (en) N-acylvanillinamide derivatives capable of activating peripheral cannabinoid receptors
IL131663A0 (en) Ophthalmic composition
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
ES2080031T1 (es) Preparacion oftalmologica.
AU1413799A (en) Non-aqueous, heterogeneous polymerization process and reaction product obtained thereby
IL109532A (en) Compositions comprising coumarin derivatives in the form of solid dispersions
NO963130L (no) Preparat for behandling av glaukom, omfattende pilokarpin og en betablokker

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20000306

AKX Designation fees paid

Free format text: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 20000629